When Bitwise Asset Management launched its Bitcoin ETF in January 2024, it made a promise: hand over 10% of gross profits every year to the people who keep BitcoinWhen Bitwise Asset Management launched its Bitcoin ETF in January 2024, it made a promise: hand over 10% of gross profits every year to the people who keep Bitcoin

Bitwise Backs Bitcoin Devs With Over $380K In Donations

2026/03/06 07:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

When Bitwise Asset Management launched its Bitcoin ETF in January 2024, it made a promise: hand over 10% of gross profits every year to the people who keep Bitcoin running. Fourteen months later, that promise is still being kept — and the checks are getting bigger.

A Growing Commitment To Open-Source Work

The firm announced a $233,000 donation on March 4, directed at three organizations that fund BTC open-source developers: Brink, OpenSats, and the Human Rights Foundation’s Bitcoin Development Fund.

Combined with last year’s contribution, Bitwise has now put more than $380,000 into the hands of programmers who maintain and secure the world’s largest cryptocurrency network. None of that money came from marketing budgets or corporate goodwill gestures. It came straight from ETF profits.

The Bitcoin ETF at the center of this — ticker BITB — has pulled in over $2.5 billion in investor inflows since it launched. That growth is what drives the size of the annual donation.

As BITB grows, so does the contribution. Bitwise said as much when announcing this year’s gift, confirming that future donations will scale with the fund’s assets under management.

Bitcoin’s Invisible Workforce

Open-source developers rarely make headlines. They write code, review proposals, fix bugs, and argue over technical upgrades in public forums — mostly without pay.

The three nonprofits receiving Bitwise’s donation exist specifically to change that. Brink and OpenSats offer grants and fellowships to full-time contributors. The Human Rights Foundation’s Bitcoin Development Fund focuses on reaching developers in countries where financial freedom is most at risk.

For these organizations, corporate donations of this size are significant. The top crypto asset’s core development has no central authority and no company behind it writing paychecks. Funding comes from donors, and consistency matters.

Beyond Crypto

Bitwise has extended the same model to Ethereum. Based on reports, the firm also donated a portion of profits from its spot Ethereum ETF — ETHW — to Ethereum open-source contributors last year.

The company manages over $15 billion in assets across more than 40 products, including ETFs tied to XRP, Solana, and Dogecoin.

The broader picture is a firm using its ETF business not just to profit from crypto, but to fund the work that keeps it functional.

Whether that becomes an industry standard remains to be seen. For now, Bitwise is one of the few doing it consistently — and putting the receipts on the table every year.

Featured image from Pexels, chart from TradingView

Market Opportunity
ConstitutionDAO Logo
ConstitutionDAO Price(PEOPLE)
$0.006894
$0.006894$0.006894
-2.14%
USD
ConstitutionDAO (PEOPLE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09